326
Participants
Start Date
May 4, 2018
Primary Completion Date
April 15, 2020
Study Completion Date
April 15, 2020
Irsenontrine
Oral hypromellose capsules.
Placebo
Oral hypromellose capsules.
Columbia University, New York
Eisai Trial Site #3, Berlin
Neurological Associates of Albany, PC, Albany
University Hospital de la Timone, Marseille
University of Virginia Adult Neurology, Charlottesville
Eisai Trial Site #2, Westerstede
PMG Research of Winston-Salem, LLC, Winston-Salem
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Universitario Puerta de Hierro - Majadahonda, Majadahonda
Compass Research-Bioclinica, The Villages
Neurology Associates of Ormond Beach, Ormond Beach
Anchor Neuroscience, Pensacola
Compass Research-Bioclinica, Orlando
Miami Jewish Health-Clinical Research, Miami
Elias Research Associates (Allied Biomedical Research Institute), Miami
Pharmax Research of South Florida; Elias Research Associates, Miami
Advanced Research Consultants, Inc., Palm Beach Gardens
Eisai Trial Site #1, Kassel
Clinica Neurologica Azienda Ospedaliera di Padova, Padua
New Orleans Center for Clinical Research, Knoxville
University of Kentucky, Dept of Neurology Sanders Brown Center on Aging, Lexington
Cleveland Clinic, Lou Ruvo Center for Brain Health at Lakewood Hospital, Lakewood
Indiana University, Dept of Neurology, Indianapolis
University of Michigan, Ann Arbor
CHRU Nancy- CMRR de lorraine Hôpital de Brabois-Service de Gériatrie, Vandœuvre-lès-Nancy
Centre Memoire du CHRU de Lille, Lille
Universita Chieti, CeSI Met, Chieti
Centre d'Investigation Clinique (CIC) Hopitaux universitaires Strasbourg HOPITAL DE HAUTEPIERRE - BATIMENT AX5, Strasbourg
Centre de Recherche Clinique - Viellissement-Cerveau-Fragilite (CRC-VCF), Hopital des Charpennes, Lyon
Hopital Neurologique de Lyon, Lyon
Banner Sun Health Research Institute, Sun City
Paradigm Clinical Research Centers, Inc, San Diego
Syrentis Clinical Research, Santa Ana
Parkinsons and Movement Disorders Institute, Fountain Valley
Advanced Research Center Inc, Anaheim
Summit Research Network (Oregon) Inc., Portland
New England Institute for Clinical Research, Stamford
Kerwin Research Center, LLC, Dallas
Eisai Trial Site #20, Chiba
Eisai Trial Site #17, Fukuoka
Eisai Trial Site #8, Fujioka-shi
Eisai Trial Site #12, Maebashi
Eisai Trial Site #14, Miyoshi-shi
Eisai Trial Site #4, Otake-shi
Eisai Trial Site #2, Himeji-shi
Eisai Trial Site #23, Yokohama
Eisai Trial Site #11, Kumamoto
Eisai Trial Site #5, Nishisonogigun
Eisai Trial Site #9, Nagaoka-shi
Eisai Trial Site #3, Kurashiki-shi
Eisai Trial Site #1, Naniwa-ku
Eisai Trial Site #16, Sakai-ku, Sakai-shi
Eisai Trial Site #24, Suita-shi
Eisai Trial Site #13, Suita-shi
Eisai Trial Site #6, Kanzaki-gun
Eisai Trial Site #10, Bunkyo-ku
Eisai Trial Site #22, Mitaka-shi
Eisai Trial Site #18, Setagaya-Ku
Eisai Trial Site #19, Yanai-shi
Eisai Trial Site #25, Hiroshima
Eisai Trial Site #21, Osaka
Hospital Mutua de Terrassa, Terrassa
Institut Internacional de Neurociències Aplicades, Barcelona
Fundacio ACE, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Dementia Research Unit, Crowborough
Memory Assessment and Research Centre, Moorgreen Hospital, Southampton
Clinical Research Centre (CRC), Dundee
Queen Elizabeth University Hospital, Glasgow
West London Mental Health Trust, Isleworth
Kings College, London
Cognition Health, London
Manchester Mental Health and Social Care Trust, Manchester
Newcastle General Hospital, Newcastle
Eisai Inc.
INDUSTRY